|
| |
|
MTU391
Top 10 cancer tissue array (15 major types from Oriental and Western population), 20 cases/39 cores
|
|
| Microarray Panel: | Multiple tumor tissue microarray, 15 major types of cancer (back skin, bladder, breast, colon, rectal, kidney, liver, lung, lymph node, ovary, pancreas, prostate, skin and uterus) covering top 10 cancers both in the East and West from 12 anatomic sites. Most types have duplicates from different patients with corresponding uninvolved tissues as controls |
| Cores: | 39 |
|
| Cases: | 20 |
| Layout: | 8 cols × 5 rows |
| Core Diameter: | 2 mm |
| Thickness: | 4 µm | | Quality Control: | H&E, IHC anti-Cytokeratin | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bac - Back skin,
Bla - Bladder,
Bre - Breast,
GI- - GI-Colonrectal,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Lym - Lymph node,
Ova - Ovary,
Pan - Pancreas,
Pro - Prostate,
Ski - Skin,
Ute - Uterus
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
TNM |
Image |
|
A1 |
1 |
M |
45 |
Bladder |
Normal bladder |
– |
Image |
|
A2 |
2 |
M |
80 |
Bladder |
Transitional cell carcinoma, grade I~II |
T2N0M0 |
Image |
|
A3 |
3 |
M |
51 |
Bladder |
Transitional cell carcinoma, grade II |
T1N0M0 |
Image |
|
A4 |
4 |
F |
38 |
Breast |
Normal breast |
– |
Image |
|
A5 |
5 |
F |
37 |
Breast |
Invasive tubular mixed carcinoma |
T1N1M0 |
Image |
|
A6 |
6 |
F |
43 |
Breast |
Invasive ductual carcinoma |
T2N1M0 |
Image |
|
A7 |
7 |
M |
71 |
GI-Stomach |
Normal stomach |
– |
Image |
|
A8 |
8 |
F |
69 |
GI-Stomach |
Adenocarcinoma, grade I~II |
T2N1M0 |
Image |
|
B1 |
9 |
M |
65 |
GI-Stomach |
Adenocarcinoma, grade II~III |
T3N1M0 |
Image |
|
B2 |
10 |
F |
10//12 |
GI-Colonrectal |
Normal colon |
– |
Image |
|
B3 |
11 |
F |
60 |
GI-Colonrectal |
Colon carcinoma, grade II |
T2N1M1 |
Image |
|
B4 |
12 |
F |
85 |
GI-Colonrectal |
Rectal carcinoma, grade II~III |
T2N0M0 |
Image |
|
B5 |
13 |
F |
2 |
Kidney |
Normal kidney cortex |
– |
Image |
|
B6 |
14 |
F |
53 |
Kidney |
Clear cell carcinoma, grade II |
T1N0M0 |
Image |
|
B7 |
15 |
M |
44 |
Kidney |
Cear cell carcinoma, grade III |
T1N0M0 |
Image |
|
B8 |
16 |
M |
52 |
Liver |
Normal |
– |
Image |
|
C1 |
17 |
M |
33 |
Liver |
Hepatocellular carcinoma, grade II~II |
T2N0M0 |
Image |
|
C2 |
18 |
M |
47 |
Liver |
Hepatocellular carcinoma, grade I~II |
T2N0M0 |
Image |
|
C3 |
19 |
M |
60 |
Lung |
Normal lung |
– |
Image |
|
C4 |
20 |
M |
69 |
Lung |
Squamous cell carcinoma, grade II~III |
T2N0M0 |
Image |
|
C5 |
21 |
M |
70 |
Lung |
Adenocarcinoma, grade II |
T2N1M0 |
Image |
|
C6 |
22 |
F |
39 |
Lymph node |
Reactive |
– |
Image |
|
C7 |
23 |
M |
40 |
Lymph node |
Hodgkin's lymphoma |
– |
Image |
|
C8 |
24 |
F |
77 |
Lymph node |
NHL-B |
– |
Image |
|
D1 |
25 |
F |
16 |
Ovary |
Normal ovary |
– |
Image |
|
D2 |
26 |
F |
20 |
Ovary |
Adenocarcinoma, grade I~II |
T2N0M0 |
Image |
|
D3 |
27 |
F |
45 |
Ovary |
Adenocarcinoma, grade III |
T2aN0M0 |
Image |
|
D4 |
28 |
M |
46 |
Pancreas |
Normal pancreas |
– |
Image |
|
D5 |
29 |
F |
64 |
Pancreas |
Adenocarcinoma, grade I~II |
T1N0M0 |
Image |
|
D6 |
30 |
F |
49 |
Pancreas |
Adenocarcinoma, grade II~III |
T1N0M0 |
Image |
|
D7 |
31 |
M |
74 |
Prostate |
Normal prostate |
– |
Image |
|
D8 |
32 |
M |
54 |
Prostate |
Transitional cell carcinoma, grade II |
T1N0M0 |
Image |
|
E1 |
33 |
M |
60 |
Prostate |
Adenocarcinoma, grade II |
T1N0M0 |
Image |
|
E2 |
34 |
F |
48 |
Skin |
Normal skin (may run out) |
– |
Image |
|
E3 |
35 |
M |
67 |
Back skin |
Squamous cell carcinoma, grade II |
T2N0M0 |
Image |
|
E4 |
36 |
M |
49 |
Skin |
Melanoma, grade II |
T2N0M0 |
Image |
|
E5 |
37 |
F |
47 |
Uterus |
Normal uterus |
– |
Image |
|
E6 |
38 |
F |
43 |
Uterus |
Cervical squamous cell carcinoma, grade II |
T1N0M0 |
Image |
|
E7 |
39 |
F |
44 |
Uterus |
Endometrial adenocarcinoma, grade II |
T1bN0M0 |
Image |
† For precise diagnosis, refer to pathology description.
TNM grading:
T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum
N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes
M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis
Sorry, this tissue array cannot be compared to find overlapping cases.
|
